Karen Bergman | Vice President of Investor Relations and Corporate Communications. |
Tom Neff | CEO |
Seth Porter | VP, Fibrosis Program |
Peony Yu | CMO |
Pat Cotroneo | CFO |
Elias Kouchakji | VP, Clinical Development, Drug Safety and Pharmacovigilance |
Chris Chung | Vice President, China Operations. |
Michael Yee | Jefferies |
Holly Barra | Goldman Sachs |
Andy Hsieh | William Blair |
Geoffrey Porges | Leerink |
Joel Beatty | Citi |
Alex Pham | Mizuho Securities. |
Alex Schwartz | Stifel |
Welcome to the FibroGen Incorporated Fourth Quarter and Year End 2017 Financial Results Conference Call. My name is Agen and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Please note that this conference is being recorded. A webcast of this call will be available on the company website for two weeks from today's date.